Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 347

1.

Examining the validity of the multiple-sclerosis walking scale-12 with Rasch analysis: Results from an Italian study.

Marengo D, Rosato R, Gamberini G, Cavalla P, Gironi M, Patti F, Prosperini L, Solaro C.

Mult Scler Relat Disord. 2019 Sep 19;36:101400. doi: 10.1016/j.msard.2019.101400. [Epub ahead of print]

PMID:
31557678
2.

The Neutrophil-to-Lymphocyte Ratio is Related to Disease Activity in Relapsing Remitting Multiple Sclerosis.

D'Amico E, Zanghì A, Romano A, Sciandra M, Palumbo GAM, Patti F.

Cells. 2019 Sep 20;8(10). pii: E1114. doi: 10.3390/cells8101114.

3.

Retrospectively acquired cohort study to evaluate the long-term impact of two different treatment strategies on disability outcomes in patients with relapsing multiple sclerosis (RE.LO.DI.MS): data from the Italian MS Register.

Paolicelli D, Lucisano G, Manni A, Avolio C, Bonavita S, Brescia Morra V, Capobianco M, Cocco E, Conte A, De Luca G, De Robertis F, Gasperini C, Gatto M, Gazzola P, Lus G, Iaffaldano A, Iaffaldano P, Maimone D, Mallucci G, Maniscalco GT, Marfia GA, Patti F, Pesci I, Pozzilli C, Rovaris M, Salemi G, Salvetti M, Spitaleri D, Totaro R, Zaffaroni M, Comi G, Amato MP, Trojano M; Italian MS Register.

J Neurol. 2019 Sep 18. doi: 10.1007/s00415-019-09531-6. [Epub ahead of print]

PMID:
31535270
4.

Tracking a mass mortality outbreak of pen shell Pinna nobilis populations: A collaborative effort of scientists and citizens.

Cabanellas-Reboredo M, Vázquez-Luis M, Mourre B, Álvarez E, Deudero S, Amores Á, Addis P, Ballesteros E, Barrajón A, Coppa S, García-March JR, Giacobbe S, Casalduero FG, Hadjioannou L, Jiménez-Gutiérrez SV, Katsanevakis S, Kersting D, Mačić V, Mavrič B, Patti FP, Planes S, Prado P, Sánchez J, Tena-Medialdea J, de Vaugelas J, Vicente N, Belkhamssa FZ, Zupan I, Hendriks IE.

Sci Rep. 2019 Sep 16;9(1):13355. doi: 10.1038/s41598-019-49808-4.

5.

The caring experience in multiple sclerosis: Caregiving tasks, coping strategies and psychological well-being.

Bassi M, Cilia S, Falautano M, Grobberio M, Negri L, Niccolai C, Pattini M, Pietrolongo E, Quartuccio ME, Viterbo RG, Allegri B, Amato MP, Benin M, De Luca G, Gasperini C, Minacapelli E, Patti F, Trojano M, Delle Fave A.

Health Soc Care Community. 2019 Sep 16. doi: 10.1111/hsc.12858. [Epub ahead of print]

PMID:
31524966
6.

Cardiovascular autonomic individual profile of relapsing-remitting multiple sclerosis patients and risk of extending cardiac monitoring after first dose fingolimod.

Vanoli E, Montano N, De Angelis G, Badilini F, Mirabella M, Bonavita S, Patti F, Bianco A, Sparaco M, Chisari C, Laroni A, Frigerio F, Bartezaghi M, Rossi S, Turrini R, Mancardi G.

J Neurol Sci. 2019 Aug 8;405:116423. doi: 10.1016/j.jns.2019.116423. [Epub ahead of print]

PMID:
31520869
7.

Conversion to Secondary Progressive Multiple Sclerosis: Patient Awareness and Needs. Results From an Online Survey in Italy and Germany.

Solari A, Giovannetti AM, Giordano A, Tortorella C, Torri Clerici V, Brichetto G, Granella F, Lugaresi A, Patti F, Salvetti M, Pesci I, Pucci E, Centonze D, Danni MC, Bonavita S, Ferraro D, Gallo A, Gajofatto A, Nociti V, Grimaldi L, Grobberio M, Lanzillo R, Di Giovanni R, Gregori S, Manni A, Pietrolongo E, Bertagnoli S, Ronzoni M, Compagnucci L, Fantozzi R, Allegri B, Arena S, Buscarinu MC, Sabattini L, Quartuccio ME, Tsantes E, Confaloneri P, Tacchino A, Schiffmann I, Rahn AC, Kleiter I, Messmer Uccelli M, Barabasch A, Heesen C, The ManTra Project.

Front Neurol. 2019 Aug 22;10:916. doi: 10.3389/fneur.2019.00916. eCollection 2019.

8.

An update on the safety of treating relapsing-remitting multiple sclerosis.

Chisari CG, Toscano S, D'Amico E, Lo Fermo S, Zanghì A, Arena S, Zappia M, Patti F.

Expert Opin Drug Saf. 2019 Oct;18(10):925-948. doi: 10.1080/14740338.2019.1658741. Epub 2019 Aug 30. Review.

PMID:
31429602
9.

Are oligoclonal bands associated to lower retinal layer thickness at the time of relapsing remitting multiple sclerosis diagnosis? Evidence from an exploratory study.

D'Amico E, Zanghì A, Chisari CG, Zappia M, Patti F.

Autoimmun Rev. 2019 Oct;18(10):102365. doi: 10.1016/j.autrev.2019.102365. Epub 2019 Aug 9. No abstract available.

PMID:
31404700
10.

Lack of evidence for Toxocara infection in Italian myelitis patients.

Nicoletti A, García HH, Cicero CE, Portaro G, Giuliano L, Patti F, Sofia V, Noh J, Handali S, Zappia M.

Neurol Sci. 2019 Jul 22. doi: 10.1007/s10072-019-04017-9. [Epub ahead of print]

PMID:
31332580
11.

Use of colistin in adult patients: a cross-sectional study.

Giacobbe DR, Saffioti C, Losito AR, Rinaldi M, Aurilio C, Bolla C, Boni S, Borgia G, Carannante N, Cassola G, Ceccarelli G, Corcione S, Gasperina DD, De Rosa FG, Dentone C, Di Bella S, Di Lauria N, Feasi M, Fiore M, Fossati S, Franceschini E, Gori A, Granata G, Grignolo S, Grossi PA, Guadagnino G, Lagi F, Maraolo AE, Marinò V, Mazzitelli M, Mularoni A, Oliva A, Pace MC, Parisini A, Patti F, Petrosillo N, Pota V, Raffaelli F, Rossi M, Santoro A, Tascini C, Torti C, Trecarichi EM, Venditti M, Viale P, Signori A, Bassetti M, Del Bono V, Giannella M, Mikulska M, Tumbarello M, Viscoli C; SITA GIOVANI, (young investigators group of the Società Italiana Terapia Antinfettiva), the COLI-CROSS study group.

J Glob Antimicrob Resist. 2019 Jun 14. pii: S2213-7165(19)30153-5. doi: 10.1016/j.jgar.2019.06.009. [Epub ahead of print]

PMID:
31207379
12.

Prevalence and Incidence of Multiple Sclerosis in the City of Biancavilla.

Patti F, Caserta C, Colandonio S, Iudica ML, Maimone D, Lo Fermo S, D'Amico E, Chisari C, Mayer F, Vanacore N.

Neuroepidemiology. 2019;53(1-2):108-114. doi: 10.1159/000500600. Epub 2019 Jun 6.

PMID:
31170722
13.

Amyotrophic lateral sclerosis spatial epidemiology in the Mount Etna region, Italy.

Boumediene F, Vasta R, Rascunà C, Lo Fermo S, Volanti P, Marziolo R, Patti F, Ferrante M, Preux PM, Marin B, Giammanco S, Zappia M, Nicoletti A.

Eur J Neurol. 2019 Nov;26(11):e90-e91. doi: 10.1111/ene.14011. Epub 2019 Jun 20. No abstract available.

PMID:
31145815
14.

Pharmacoeconomics of synthetic therapies for multiple sclerosis.

D'Amico E, Chisari CG, Gitto L, Zanghì A, Toscano S, Patti F.

Expert Opin Pharmacother. 2019 Aug;20(11):1331-1340. doi: 10.1080/14656566.2019.1615880. Epub 2019 May 15. Review.

PMID:
31090469
15.

Neuraxial analgesia is not associated with an increased risk of post-partum relapses in MS.

Lavie C, Rollot F, Durand-Dubief F, Marignier R, Ionescu I, Casey R, Moreau T, Tourniaire P, Hutchinson M, D'Hooghe MB, Laplaud DA, Clavelou P, De Sèze J, Debouverie M, Brassat D, Pelletier J, Lebrun-Frenay C, Le Page E, Castelnovo G, Berger E, Hautecoeur P, Heinzlef O, Durelli L, Clerico M, Trojano M, Patti F, Vukusic S; PRIMS and POPARTMUS investigators.

Mult Scler. 2019 Apr;25(4):591-600. doi: 10.1177/1352458518763080. Epub 2018 Mar 20.

PMID:
31081475
16.

Placing CD20-targeted B cell depletion in multiple sclerosis therapeutic scenario: Present and future perspectives.

D'Amico E, Zanghì A, Gastaldi M, Patti F, Zappia M, Franciotta D.

Autoimmun Rev. 2019 Jul;18(7):665-672. doi: 10.1016/j.autrev.2019.05.003. Epub 2019 May 3. Review.

PMID:
31059839
17.

Illness perceptions and psychological adjustment among persons with multiple sclerosis: the mediating role of coping strategies and social support.

Bassi M, Cilia S, Falautano M, Grobberio M, Niccolai C, Pattini M, Pietrolongo E, Quartuccio ME, Viterbo RG, Allegri B, Amato MP, Benin M, De Luca G, Gasperini C, Minacapelli E, Patti F, Trojano M, Delle Fave A.

Disabil Rehabil. 2019 May 6:1-13. doi: 10.1080/09638288.2019.1610511. [Epub ahead of print]

PMID:
31056979
18.

Cancer Risk and Multiple Sclerosis: Evidence From a Large Italian Cohort.

D'Amico E, Chisari CG, Arena S, Zanghì A, Toscano S, Lo Fermo S, Maimone D, Castaing M, Sciacca S, Zappia M, Patti F.

Front Neurol. 2019 Apr 10;10:337. doi: 10.3389/fneur.2019.00337. eCollection 2019.

19.

Aging with multiple sclerosis: prevalence and profile of cognitive impairment.

Branco M, Ruano L, Portaccio E, Goretti B, Niccolai C, Patti F, Chisari C, Gallo P, Grossi P, Ghezzi A, Roscio M, Mattioli F, Bellomi F, Simone M, Viterbo RG, Amato MP.

Neurol Sci. 2019 Aug;40(8):1651-1657. doi: 10.1007/s10072-019-03875-7. Epub 2019 Apr 23.

PMID:
31011932
20.

Clinical, laboratory features, and prognostic factors in adult acute transverse myelitis: an Italian multicenter study.

Annunziata P, Masi G, Cioni C, Gastaldi M, Marchioni E, D'amico E, Patti F, Laroni A, Mancardi G, Vitetta F, Sola P.

Neurol Sci. 2019 Jul;40(7):1383-1391. doi: 10.1007/s10072-019-03830-6. Epub 2019 Mar 22.

PMID:
30903415
21.

Correction to: Cognitive assessment in multiple sclerosis-an Italian consensus.

Amato MP, Morra VB, Falautano M, Ghezzi A, Goretti B, Patti F, Riccardi A, Mattioli F.

Neurol Sci. 2019 May;40(5):1097. doi: 10.1007/s10072-019-03852-0.

PMID:
30900096
22.

Correction to: The Italian multiple sclerosis register.

Trojano M, Bergamaschi R, Amato MP, Comi G, Ghezzi A, Lepore V, Marrosu MG, Mosconi P, Patti F, Ponzio M, Zaratin P, Battaglia MA; Italian Multiple Sclerosis Register Centers Group.

Neurol Sci. 2019 Apr;40(4):907. doi: 10.1007/s10072-019-03772-z.

PMID:
30815752
23.

Management of dysphagia in multiple sclerosis: current best practice.

D'Amico E, Zanghì A, Serra A, Murabito P, Zappia M, Patti F, Cocuzza S.

Expert Rev Gastroenterol Hepatol. 2019 Jan;13(1):47-54. doi: 10.1080/17474124.2019.1544890. Epub 2018 Nov 15. Review.

PMID:
30791843
24.

Lack of association between Toxocara canis and multiple sclerosis: A population-based case-control study.

Cicero CE, Patti F, Lo Fermo S, Giuliano L, Rascunà C, Chisari CG, D'Amico E, Paradisi V, Marin B, Preux PM, Mantella A, Bartoloni A, Zappia M, Nicoletti A.

Mult Scler. 2019 Feb 11:1352458518825394. doi: 10.1177/1352458518825394. [Epub ahead of print] No abstract available.

PMID:
30741090
25.

Newest evidence for tetrahydrocannabinol:cannabidiol oromucosal spray from postapproval pragmatic studies.

Patti F.

Neurodegener Dis Manag. 2019 Apr;9(2s):3-7. doi: 10.2217/nmt-2018-0049. Epub 2019 Jan 18.

PMID:
30657027
26.

Chiral optical tweezers for optically active particles in the T-matrix formalism.

Patti F, Saija R, Denti P, Pellegrini G, Biagioni P, Iatì MA, Maragò OM.

Sci Rep. 2019 Jan 10;9(1):29. doi: 10.1038/s41598-018-36434-9.

27.

Discontinuation of teriflunomide and dimethyl fumarate in a large Italian multicentre population: a 24-month real-world experience.

D'Amico E, Zanghì A, Sciandra M, Borriello G, Callari G, Gallo A, Salemi G, Cottone S, Buccafusca M, Valentino P, Bossio RB, Grimaldi LME, Pozzilli C, Tedeschi G, Zappia M, Patti F.

J Neurol. 2019 Feb;266(2):411-416. doi: 10.1007/s00415-018-9144-9. Epub 2018 Dec 4.

PMID:
30515629
28.

Effectiveness and safety of Rituximab in demyelinating diseases spectrum: An Italian experience.

D'Amico E, Zanghì A, Chisari CG, Fermo SL, Toscano S, Arena S, Patti F, Zappia M.

Mult Scler Relat Disord. 2019 Jan;27:324-326. doi: 10.1016/j.msard.2018.09.041. Epub 2018 Oct 3.

PMID:
30471585
29.

The Italian multiple sclerosis register.

Trojano M, Bergamaschi R, Amato MP, Comi G, Ghezzi A, Lepore V, Marrosu MG, Mosconi P, Patti F, Ponzio M, Zaratin P, Battaglia MA; Italian Multiple Sclerosis Register Centers Group.

Neurol Sci. 2019 Jan;40(1):155-165. doi: 10.1007/s10072-018-3610-0. Epub 2018 Nov 13. Erratum in: Neurol Sci. 2019 Apr;40(4):907.

30.

Noise⁻Seeded Developmental Pattern Formation in Filamentous Cyanobacteria.

Arbel-Goren R, Di Patti F, Fanelli D, Stavans J.

Life (Basel). 2018 Nov 9;8(4). pii: E58. doi: 10.3390/life8040058. Review.

31.

Authors' Response to the Letter to the Editor Regarding: A Comprehensive Review on Copemyl®.

Annovazzi P, Bertolotto A, Brescia Morra V, Gasperini C, Montanari E, Navarra P, Patti F, Pia Sormani M, Ghezzi A.

Neurol Ther. 2018 Dec;7(2):391-393. doi: 10.1007/s40120-018-0116-x. Epub 2018 Nov 10. No abstract available.

32.

No evidence of disease activity (NEDA-3) and disability improvement after alemtuzumab treatment for multiple sclerosis: a 36-month real-world study.

Prosperini L, Annovazzi P, Boffa L, Buscarinu MC, Gallo A, Matta M, Moiola L, Musu L, Perini P, Avolio C, Barcella V, Bianco A, Farina D, Ferraro E, Pontecorvo S, Granella F, Grimaldi LME, Laroni A, Lus G, Patti F, Pucci E, Pasca M, Sarchielli P; Italian Alemtuzumab Study Group.

J Neurol. 2018 Dec;265(12):2851-2860. doi: 10.1007/s00415-018-9070-x. Epub 2018 Sep 26.

PMID:
30259178
33.

Static postural control disturbances among the different multiple sclerosis phenotypes: A Neurocom Balance Manager® evaluation study.

Cimino V, Chisari CG, Raciti G, Pappalardo A, Zappia M, Patti F.

Mult Scler Relat Disord. 2018 Nov;26:46-51. doi: 10.1016/j.msard.2018.08.024. Epub 2018 Sep 8.

PMID:
30223228
34.

Comparable efficacy and safety of dimethyl fumarate and teriflunomide treatment in Relapsing-Remitting Multiple Sclerosis: an Italian real-word multicenter experience.

D'Amico E, Zanghì A, Callari G, Borriello G, Gallo A, Graziano G, Valentino P, Buccafusca M, Cottone S, Salemi G, Ragonese P, Bossio RB, Docimo R, Grimaldi LME, Pozzilli C, Tedeschi G, Zappia M, Patti F.

Ther Adv Neurol Disord. 2018 Sep 10;11:1756286418796404. doi: 10.1177/1756286418796404. eCollection 2018.

35.

Predictors of relapse and disability progression in MS patients who discontinue disease-modifying therapy.

Kister I, Spelman T, Patti F, Duquette P, Trojano M, Izquierdo G, Lugaresi A, Grammond P, Sola P, Ferraro D, Grand'Maison F, Alroughani R, Terzi M, Boz C, Hupperts R, Lechner-Scott J, Kappos L, Pucci E, Hodgkinson S, Solaro C, Butzkueven H.

J Neurol Sci. 2018 Aug 15;391:72-76. doi: 10.1016/j.jns.2018.06.001. Epub 2018 Jun 2.

PMID:
30103975
36.

Patient and caregiver involvement in the formulation of guideline questions: findings from the European Academy of Neurology guideline on palliative care of people with severe multiple sclerosis.

Köpke S, Giordano A, Veronese S, Christin Rahn A, Kleiter I, Basedow-Rajwich B, Fornari A, Battaglia MA, Drulovic J, Kooij L, Koops J, Mens J, Meza Murillo ER, Milanov I, Milo R, Patti F, Pekmezovic T, Sastre-Garriga J, Vosburgh J, Voltz R, Bay J, Oliver DJ, Solari A.

Eur J Neurol. 2019 Jan;26(1):41-50. doi: 10.1111/ene.13760. Epub 2018 Sep 9.

PMID:
30035845
37.

Participant perspectives of a home-based palliative approach for people with severe multiple sclerosis: A qualitative study.

Giovannetti AM, Borreani C, Bianchi E, Giordano A, Cilia S, Cipollari S, Rossi I, Cavallaro C, Torri Clerici V, Rossetti E, Stefanelli MC, Totis A, Pappalardo A, Occhipinti G, Confalonieri P, Veronese S, Grasso MG, Patti F, Zaratin P, Battaglia MA, Solari A; PeNSAMI project.

PLoS One. 2018 Jul 12;13(7):e0200532. doi: 10.1371/journal.pone.0200532. eCollection 2018.

38.

Late-onset and young-onset relapsing-remitting multiple sclerosis: evidence from a retrospective long-term follow-up study.

D'Amico E, Patti F, Zanghì A, Chisari CG, Lo Fermo S, Zappia M.

Eur J Neurol. 2018 Dec;25(12):1425-1431. doi: 10.1111/ene.13745. Epub 2018 Aug 3.

PMID:
29956427
39.

Cognitive assessment in multiple sclerosis-an Italian consensus.

Amato MP, Morra VB, Falautano M, Ghezzi A, Goretti B, Patti F, Riccardi A, Mattioli F.

Neurol Sci. 2018 Aug;39(8):1317-1324. doi: 10.1007/s10072-018-3427-x. Epub 2018 May 15. Erratum in: Neurol Sci. 2019 May;40(5):1097.

PMID:
29766386
40.

eMSQOL-29: Prospective validation of the abbreviated, electronic version of MSQOL-54.

Rosato R, Testa S, Bertolotto A, Scavelli F, Giovannetti AM, Confalonieri P, Patti F, Chisari CG, Lugaresi A, Pietrolongo E, Grasso MG, Rossi I, Toscano A, Loera B, Giordano A, Solari A.

Mult Scler. 2019 May;25(6):856-866. doi: 10.1177/1352458518774935. Epub 2018 May 15.

41.

Hopping in the Crowd to Unveil Network Topology.

Asllani M, Carletti T, Di Patti F, Fanelli D, Piazza F.

Phys Rev Lett. 2018 Apr 13;120(15):158301. doi: 10.1103/PhysRevLett.120.158301.

PMID:
29756854
42.

Robust stochastic Turing patterns in the development of a one-dimensional cyanobacterial organism.

Di Patti F, Lavacchi L, Arbel-Goren R, Schein-Lubomirsky L, Fanelli D, Stavans J.

PLoS Biol. 2018 May 4;16(5):e2004877. doi: 10.1371/journal.pbio.2004877. eCollection 2018 May.

43.

Lateral switch to IFN beta-1a 44 mcg may be effective as escalation switch to fingolimod in selected persons with relapsing remitting multiple sclerosis: a real-world setting experience.

D'Amico E, Patti F, Zanghì A, Lo Fermo S, Chisari CG, Zappia M.

Expert Rev Clin Pharmacol. 2018 May;11(5):531-536. doi: 10.1080/17512433.2018.1449643. Epub 2018 Mar 13.

PMID:
29521113
44.

Pregnancy decision-making in women with multiple sclerosis treated with natalizumab: I: Fetal risks.

Portaccio E, Annovazzi P, Ghezzi A, Zaffaroni M, Moiola L, Martinelli V, Lanzillo R, Brescia Morra V, Rinaldi F, Gallo P, Tortorella C, Paolicelli D, Pozzilli C, De Giglio L, Cavalla P, Cocco E, Marrosu MG, Patti F, Solaro C, Bellantonio P, Uccelli A, Laroni A, Pastò L, Giannini M, Trojano M, Comi G, Amato MP; MS Study Group of the Italian Neurological Society.

Neurology. 2018 Mar 6;90(10):e823-e831. doi: 10.1212/WNL.0000000000005067. Epub 2018 Feb 7.

PMID:
29438046
45.

Identifying neuropathic pain in patients with multiple sclerosis: a cross-sectional multicenter study using highly specific criteria.

Solaro C, Cella M, Signori A, Martinelli V, Radaelli M, Centonze D, Sica F, Grasso MG, Clemenzi A, Bonavita S, Esposito S, Patti F, D'Amico E, Cruccu G, Truini A; Neuropathic Pain Special Interest Group of the Italian Neurological Society.

J Neurol. 2018 Apr;265(4):828-835. doi: 10.1007/s00415-018-8758-2. Epub 2018 Feb 5.

PMID:
29404736
46.

Botulinum Toxin A for Sialorrhoea Associated with Neurological Disorders: Evaluation of the Relationship between Effect of Treatment and the Number of Glands Treated.

Restivo DA, Panebianco M, Casabona A, Lanza S, Marchese-Ragona R, Patti F, Masiero S, Biondi A, Quartarone A.

Toxins (Basel). 2018 Jan 27;10(2). pii: E55. doi: 10.3390/toxins10020055.

47.

Long-term follow-up of pediatric MS patients starting treatment with injectable first-line agents: A multicentre, Italian, retrospective, observational study.

Baroncini D, Zaffaroni M, Moiola L, Lorefice L, Fenu G, Iaffaldano P, Simone M, Fanelli F, Patti F, D'Amico E, Capobianco M, Bertolotto A, Gallo P, Margoni M, Miante S, Milani N, Amato MP, Righini I, Bellantonio P, Scandellari C, Costantino G, Scarpini E, Bergamaschi R, Mallucci G, Comi G, Ghezzi A.

Mult Scler. 2019 Mar;25(3):399-407. doi: 10.1177/1352458518754364. Epub 2018 Jan 24. Erratum in: Mult Scler. 2019 Oct;25(11):NP33.

PMID:
29363396
48.

Pharmacokinetic drug evaluation of daclizumab for the treatment of relapsing-remitting multiple sclerosis.

Patti F, Chisari CG, D'Amico E, Zappia M.

Expert Opin Drug Metab Toxicol. 2018 Mar;14(3):341-352. doi: 10.1080/17425255.2018.1432594. Epub 2018 Jan 30. Review.

PMID:
29363337
49.

Beyond Disease: Happiness, Goals, and Meanings among Persons with Multiple Sclerosis and Their Caregivers.

Delle Fave A, Bassi M, Allegri B, Cilia S, Falautano M, Goretti B, Grobberio M, Minacapelli E, Pattini M, Pietrolongo E, Valsecchi M, Amato MP, Lugaresi A, Patti F.

Front Psychol. 2017 Dec 20;8:2216. doi: 10.3389/fpsyg.2017.02216. eCollection 2017.

50.

Single incision extended video assisted transcervical thymectomy.

Migliore M, Criscione A, Nardini M, Patti F, Borrata F.

J Vis Surg. 2017 Oct 28;3:154. doi: 10.21037/jovs.2017.10.06. eCollection 2017. No abstract available.

Supplemental Content

Support Center